Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where David M. Morens is active.

Publication


Featured researches published by David M. Morens.


Microbiology and Immunology | 1985

Comparison of Dengue Virus Plaque Reduction Neutralization by Macro and ‘Semi‐Micro’ Methods in LLC‐MK2 Cells

David M. Morens; Scott B. Halstead; Linda K. Larsen

A simplified ‘Semi‐Micro’ plaque reduction neutralization test (PRNT) for dengue antibody in LLC‐MK2 cells in disposable tissue culture plates is described. The assay compares favorably with the standard PRNT in glass prescription bottles, with relative sensitivity and specificity both 100% at a 1: 40 screening dilution by 70% plaque reduction criteria. The assay is easy to perform, economical of time, expense, and storage space, and is suitable for study of sera available in small volumes, such as those obtained on filter paper or by the capillary method. The LLC‐MK2 semi‐micro PRNT is an acceptable alternative to the standard PRNT, particularly in laboratories that use these cells routinely for other tissue culture work and for flavivirus vaccine development.


Emerging Infectious Diseases | 1996

AIDS and AAA in Egypt

Robert J. Littman; David M. Morens

7. Miller RL, Armelagos GJ, Ikram S, de Jonge N, Krijger FW, Deelder AM. Paleoepidemiology of Schistosoma infection in mummies. Br Med J 1992;304:555-6. 8. Capron A, Dessaint JP, Capron M, Ouma JH, Butterworth AE. Immunity to schistosomes: Progress toward a vaccine. Science 1987;238:1065-72. 9. Gryseels B, Stelma FF, Talla I, van Dam GJ, Polman K, Sow S, et al. Epidemiology, immunology and chemotherapy of Schistosoma mansoni infections in a recently exposed community in Senegal. Trop Geogr Med 1994;46:209-19. 10. El Alamy MA, Cline BL. Prevalence and intensity of Schistosoma haematobium and S. mansoni infection in Qalyub, Egypt. Am J Trop Med Hyg 1977;26:470-2.


Clinical Infectious Diseases | 1994

Antibody-Dependent Enhancement of Infection and the Pathogenesis of Viral Disease

David M. Morens


American Journal of Epidemiology | 1994

Prospective Study of Cigarette Smoking and the Risk of Developing Idiopathic Parkinson's Disease

Andrew Grandinetti; David M. Morens; Dwayne Reed; Dorothy MacEachern


American Journal of Epidemiology | 1996

Observations on Serum Uric Acid Levels and the Risk of Idiopathic Parkinson's Disease

J. W. Davis; Andrew Grandinetti; C. J. Waslien; G. W. Ross; Lon R. White; David M. Morens


Journal of General Virology | 1990

Measurement of antibody-dependent infection enhancement of four dengue virus serotypes by monoclonal and polyclonal antibodies

David M. Morens; Scott B. Halstead


Clinical Infectious Diseases | 1992

Severe Streptococcal Infections in Historical Perspective

Alan R. Katz; David M. Morens


Microbial Pathogenesis | 1987

Profiles of antibody-dependent enhancement of dengue virus type 2 infection☆

David M. Morens; Scott B. Halstead; Nyven J. Marchette


Journal of Medical Virology | 1987

Disease severity-related antigenic differences in dengue 2 strains detected by dengue 4 monoclonal antibodies

David M. Morens; Scott B. Halstead


Transactions of the American Philological Association | 1992

Epidemiology of the Plague of Athens

David M. Morens; Robert J. Littman

Collaboration


Dive into the David M. Morens's collaboration.

Top Co-Authors

Avatar

Scott B. Halstead

Uniformed Services University of the Health Sciences

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Andrew Grandinetti

University of Hawaii at Manoa

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge